We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

AXA Framlington Biotech Class Z - Income (GBP)

Sell:193.50p Buy:193.50p Change: 0.20p (0.10%)
Prices as at 22 July 2024
Sell:193.50p
Buy:193.50p
Change: 0.20p (0.10%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 22 July 2024
Sell:193.50p
Buy:193.50p
Change: 0.20p (0.10%)
Prices as at 22 July 2024
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 93.85%
UK Equities 3.66%
Cash and Equiv. 2.48%

Top 10 holdings

Stock name % Weight Country Sector
1 REGENERON PHARMACEUTICALS INC 8.95% United States Pharmaceuticals & Biotechnology
2 VERTEX PHARMACEUTICALS INC 7.03% United States Pharmaceuticals & Biotechnology
3 AMGEN 6.00% United States Pharmaceuticals & Biotechnology
4 BIOGEN 4.74% United States Pharmaceuticals & Biotechnology
5 NOVO NORDISK A/S 3.23% Denmark Pharmaceuticals & Biotechnology
6 MODERNA 3.15% United States Pharmaceuticals & Biotechnology
7 NEUROCRINE BIOSCIENCES INC 2.85% United States Pharmaceuticals & Biotechnology
8 GILEAD SCIENCES INC 2.80% United States Pharmaceuticals & Biotechnology
9 ARGENX SE 2.56% Netherlands Pharmaceuticals & Biotechnology
10 ELI LILLY AND COMPANY 2.46% United States Pharmaceuticals & Biotechnology

Where is the fund invested?

UK
Equities
Int'l
Equities
UK
Bonds
Int'l
Bonds
UK
Gilts
Managed Funds Property Other Cash and Equiv. Total
Health Care 3.66% 93.85% 97.52%
Cash and Equiv. 2.48% 2.48%
Total 3.66% 93.85% 2.48% 100.00%
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Data as at 31 March 2024. Data provided by Broadridge.

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account